The main function of Rasayan is longevity and good health
On May 28, 2026, Frances Health Ministry confirmed what the pharmaceutical industry had been anticipating for eighteen months: Wegovy and Mounjaro will be reimbursed through the French public health system for severe obesity, effective June 15, 2026
For example, a monthly supply of Zepbound or Wegovy can cost anywhere from $499 to $1,500
Conclusion Overall, when it comes to prescribing GLP1-RAs for weight loss to patients with a history of cholelithiasis or other gallbladder disorders, providers should use caution
Lipid improvements with GLP-1 agonists tend to reverse after discontinuation due to weight regain, which is worth considering when discussing them as alternatives to statins
Meanwhile, alcohol producersalready dealing with a generation drinking lessnow face an additional headwind